SRF Limited

BSE:503806 주식 리포트

시가총액: ₹776.6b

SRF 과거 순이익 실적

과거 기준 점검 4/6

SRF의 수입은 연평균 -2.8%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 6.7% 증가했습니다. 매출은 연평균 7.5%의 비율로 증가해 왔습니다. SRF의 자기자본이익률은 13.1%이고 순이익률은 11.6%입니다.

핵심 정보

-2.82%

순이익 성장률

-2.98%

주당순이익(EPS) 성장률

Chemicals 산업 성장률17.68%
매출 성장률7.54%
자기자본이익률13.07%
순이익률11.63%
최근 순이익 업데이트31 Mar 2026

최근 과거 실적 업데이트

Recent updates

내러티브 업데이트 • Apr 30

503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support

The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).
내러티브 업데이트 • Apr 08

503806: Fair View As Higher Margins Offset Lower Future P/E Multiple

Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.
내러티브 업데이트 • Mar 24

503806: Elevated P E And Margins Will Likely Restrain Future Returns

Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
내러티브 업데이트 • Mar 09

503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns

Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.
내러티브 업데이트 • Feb 23

503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns

Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.
내러티브 업데이트 • Feb 09

503806: Lower Margins And Rich P E Will Likely Pressure Returns

Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
내러티브 업데이트 • Jan 24

503806: New Pharma Plant And CFO Appointment Will Support Future Upside

Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).
내러티브 업데이트 • Jan 10

503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects

Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.
내러티브 업데이트 • Dec 26

503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability

Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).
내러티브 업데이트 • Dec 12

503806: Lower Discount Rate May Support Stronger Long Term Profitability

Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.
내러티브 업데이트 • Nov 27

503806: CFO Transition And New Facility Approval Will Drive Upside Ahead

Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.
내러티브 업데이트 • Nov 12

503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook

Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.
내러티브 업데이트 • Oct 29

New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead

Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.
내러티브 업데이트 • Oct 15

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).
내러티브 업데이트 • Sep 05

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
User avatar
새로운 내러티브 • Nov 28

Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey

SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.

매출 및 비용 세부 내역

SRF가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.

순이익 및 매출 추이

BSE:503806 매출, 비용 및 순이익 (INR Millions)
날짜매출순이익일반관리비연구개발비
31 Mar 26157,86518,35211,4830
31 Dec 25154,84717,79211,5480
30 Sep 25152,63516,17611,3470
30 Jun 25150,47614,30911,1100
31 Mar 25146,93112,50810,8590
31 Dec 24139,49511,46910,5470
30 Sep 24135,11211,29310,3780
30 Jun 24132,64312,28610,1100
31 Mar 24131,38513,3579,7680
31 Dec 23133,46914,7609,4220
30 Sep 23137,63517,3349,0860
30 Jun 23143,13919,1368,7720
31 Mar 23148,70321,6238,5350
31 Dec 22146,41622,0558,4350
30 Sep 22145,17822,0028,4010
30 Jun 22136,29021,0168,2260
31 Mar 22124,33718,8898,1040
31 Dec 21114,91916,6477,5970
30 Sep 21102,92414,8347,1080
30 Jun 2195,54314,1676,6590
31 Mar 2184,00011,9836,3930
31 Dec 2076,50210,1106,0790
30 Sep 2073,54310,3225,8680
30 Jun 2069,9139,1745,6520
31 Mar 2072,0949,1595,5670
31 Dec 1978,8179,5116,0600
30 Sep 1978,4117,5925,8620
30 Jun 1971,2166,3314,9930
31 Mar 1970,9965,9164,9010
31 Dec 1872,3295,7475,3060
30 Sep 1866,6605,4025,1990
30 Jun 1860,3704,9174,7770
31 Mar 1855,8904,6175,0350
31 Dec 1753,0264,6704,9510
30 Sep 1750,3854,4424,8270
30 Jun 1748,9524,6424,4650
31 Mar 1748,2185,1504,5850
31 Dec 1645,8334,7874,4910
30 Sep 1645,4594,7094,3630
30 Jun 1645,9804,5374,0160
31 Mar 1645,9274,2994,0940
31 Dec 1545,3533,7465,7880
30 Sep 1545,5113,4535,7220
30 Jun 1545,7593,2355,7010

양질의 수익: 503806는 고품질 수익을 보유하고 있습니다.

이익 마진 증가: 503806의 현재 순 이익률 (11.6%)은 지난해 (8.5%)보다 높습니다.

잉여현금흐름 대비 순이익 분석

과거 순이익 성장 분석

수익추이: 503806의 수익은 지난 5년 동안 연평균 2.8% 감소했습니다.

성장 가속화: 지난 1년간 503806 의 수익 증가율(46.7%)은 연간 평균(-2.8%)을 초과합니다.

수익 대 산업: 503806의 지난 1년 수익 증가율(46.7%)은 Chemicals 업계의 9.5%를 상회했습니다.

자기자본이익률

높은 ROE: 503806의 자본 수익률(13.1%)은 낮음으로 평가됩니다.

총자산이익률

투하자본수익률

우수한 과거 실적 기업을 찾아보세요

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/21 19:40
종가2026/05/21 00:00
수익2026/03/31
연간 수익2026/03/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

SRF Limited는 42명의 분석가가 다루고 있습니다. 이 중 31명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
null null360 ONE Capital Market Private Limited
Kumar Saumya SinghAmbit Capital
Nitin BhasinAmbit Capital